The luciferase-SNIPR T-cell signal was stronger within the HER2+ tumor, which is maximized at day 9, likely reflecting active proliferation within the tumor microenvironment (145-fold, no P value) (Supplemental Figs. 6D and 6E). The gene discussed is ERBB2; the disease is neoplasm.